MPH Health Care AG
XETRA:93M1
MPH Health Care AG
XETRA:93M1
Price:
26.2 EUR
2.34%
Updated:
May 16, 2024
MPH Health Care AG
Cash from Financing Activities
|
MPH Health Care AG
Cash from Financing Activities Peer Comparison
Comparables:
ATAI
BAYN
MRK
DMP
PSG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Financing Activities
-€3.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Financing Activities
-$8.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Cash from Financing Activities
-€679m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
Merck KGaA
XETRA:MRK
|
Cash from Financing Activities
-€1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-5%
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Financing Activities
€204.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Financing Activities
-€12.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is MPH Health Care AG's Cash from Financing Activities?
Cash from Financing Activities
-3.2m
EUR
-3.2m
EUR
Based on the financial report for Dec 31, 2022, MPH Health Care AG's Cash from Financing Activities amounts to -3.2m EUR.
What is MPH Health Care AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
11%
11%
Over the last year, the Cash from Financing Activities growth was -1 451%. The average annual Cash from Financing Activities growth rates for MPH Health Care AG have been 30% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
